EFPIA - NEWSLETTER

EFPIA Newsletter 27 October 2022

The pharmaceutical legislation is a once-in-a-generation opportunity: let’s make sure the focus is right

The pharmaceutical industry had been looking forward to the revision of legislation as an opportunity to fix long-standing problems, update a 20-year-old regulatory system and make it fit for purpose for the innovations of the future.

But, somewhere along the line, the ambition moved from future-proofing an outdated regulatory framework to fixing national prerogatives, such as access and uptake of medicines, via EU legislation.

The proposed changes being put forward — on top of the impact of the perma-crisis — risk alienating this dynamic industry from Europe even further.

News

26 October 2022 Joint Statement Pharmaceutical industry concerns over the implementation of the EU HTA Regulation...

We call for a constructive dialogue with the European Commission and the newly established Coordination Group, to ensure...

Blogs

26 October 2022 Rare diseases and paediatric medicines: a European success story

Europe has come a long way in advancing rare and paediatric diseases and we have many miles still to go. But we now...

25 October 2022 Leveraging early cancer care for an aging population: how to ensure health systems can be resilient...

As science and technology evolve, the ways we detect, monitor and manage disease within our health systems must evolve...

An EU Health Technology Assessment can help deliver medicines to patients, faster

According to the EFPIA WAIT Indicator, France ranks 15th in Europe in terms of time of medicines availability to patients.
The European HTA regulation provides solutions to accelerate access to medicines for patients.
Watch Nathalie Moll's interview with G5 Santé here.

Events

02 NOV 2022

Innovation in pharmaceuticals is changing the world. How to ensure their availability... Riga, Latvia

Learn more →

11 NOV 2022

A New Era for Health Care in Cyprus: Embrace, Evaluate, Evolve University of Nicosia, Cyprus

Organised by KEFEA in collaboration with EFPIA. Under the auspices of the Ministry of Health of the Republic of Cyprus....

Learn more →

Early diagnosis can make the difference between life and death

Europe's Beating Cancer Plan is a unique opportunity to improve outcomes for people living with cancer: extending access to screening for breast, colorectal & cervical cancers and introducing prostate, lung and gastric cancer testing can help save lives.
Read more

What we are reading

Biotechs, developing countries vaccine manufacturers and pharma unite behind a proposal to... 23 October 2022 (IFPMA)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶